Robert McManus
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Robert McManus has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Ali Mortezaei
Student Research Committee, Gonabad University of Medical Sciences, Gonabad, Iran
1 shared publication Amir H. Faraji
Clinical Innovations Laboratory, Houston Methodist Research Institute, Houston, TX, United States; Department of Neurological Surgery, Houston Methodist Hospital, Houston, TX, United States
1 shared publication- Ashley Centner
Department of Psychology, Binghamton University, Binghamton, NY 13902, USA
1 shared publication - Barbara Buccilli
Department of Neurosurgery, Houston Methodist, Houston, TX, USA
1 shared publication - Christopher Bishop
Department of Psychology, Binghamton University, Binghamton, NY 13902, USA
1 shared publication - John D. Patterson
Clinical Innovations Laboratory, Houston Methodist Research Institute, Houston, TX, United States; Department of Neurological Surgery, Houston Methodist Hospital, Houston, TX, United States
1 shared publication
Latest Publications
- Open Access
- 28 April 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (9) , 3923
Preservation of Extracellular and Tissue Dopamine During Tyrosine Hydroxylase Loss in Rat 6-OHDA Parkinson’s Model: Selective Compensation Restricted to Substantia Nigra
Compensatory mechanisms are thought to maintain sufficient dopamine (DA) signaling to mitigate locomotor impairment during progressive nigrostriatal neuron loss in Parkinson’s disease (PD). Recent evidence indicated augmented DA tissue content in the substantia nigra (SN), not striatum, compensates for tyrosine hydroxylase (TH) and neuronal loss, and alleviates the severity of hypokinesia during neuronal loss. Here, we determined if increased extracellular DA in the SN may also be a compensatory mechanism to augment DA signaling. Following unilateral 6-hydroxydopamine (6-OHDA) lesion or sham-operation, we contemporaneously evaluated extracellular DA against both DA tissue and TH levels in striatum and SN at 7 and 28 days. At 7 days post-lesion, TH loss exceeded ~90% in striatum, and ~70% in the SN. The severity of DA tissue loss coincided with TH protein loss only in striatum (>90%) on both days after lesion, whereas in the SN, DA loss was absent on day 7 and significantly less than TH loss by day 28. Whereas there was a robust increase in extracellular DA in striatum in our sham-operation group, the severe TH and DA tissue loss in striatum practically abolished KCl (K+)-stimulated extracellular DA by day 7. In contrast, whereas striatal K+-stimulation had no effect on extracellular DA in the SN in sham-operation group, extracellular DA levels increased in the SN 7 days after nigrostriatal lesion: an increase no longer apparent by day 28. Thus, despite significant loss of TH protein loss in the SN, extracellular and tissue DA tissue levels were augmented during neuronal loss. These results build upon evidence that compensatory mechanisms to augment DA signaling are not engaged in striatum, and point to the SN as the locus of augmented DA signaling to offset loss of TH during nigrostriatal neuron loss.
- 28 April 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (9) , 3923
Open AccessPreservation of Extracellular and Tissue Dopamine During Tyrosine Hydroxylase Loss in Rat 6-OHDA Parkinson’s Model: Selective Compensation Restricted to Substantia Nigra
Compensatory mechanisms are thought to maintain sufficient dopamine (DA) signaling to mitigate locomotor impairment during progressive nigrostriatal neuron loss in Parkinson’s disease (PD). Recent evidence indicated augmented DA tissue content in the substantia nigra (SN), not striatum, compensates for tyrosine hydroxylase (TH) and neuronal loss, and alleviates the severity of hypokinesia during neuronal loss. Here, we determined if increased extracellular DA in the SN may also be a compensatory mechanism to augment DA signaling. Following unilateral 6-hydroxydopamine (6-OHDA) lesion or sham-operation, we contemporaneously evaluated extracellular DA against both DA tissue and TH levels in striatum and SN at 7 and 28 days. At 7 days post-lesion, TH loss exceeded ~90% in striatum, and ~70% in the SN. The severity of DA tissue loss coincided with TH protein loss only in striatum (>90%) on both days after lesion, whereas in the SN, DA loss was absent on day 7 and significantly less than TH loss by day 28. Whereas there was a robust increase in extracellular DA in striatum in our sham-operation group, the severe TH and DA tissue loss in striatum practically abolished KCl (K+)-stimulated extracellular DA by day 7. In contrast, whereas striatal K+-stimulation had no effect on extracellular DA in the SN in sham-operation group, extracellular DA levels increased in the SN 7 days after nigrostriatal lesion: an increase no longer apparent by day 28. Thus, despite significant loss of TH protein loss in the SN, extracellular and tissue DA tissue levels were augmented during neuronal loss. These results build upon evidence that compensatory mechanisms to augment DA signaling are not engaged in striatum, and point to the SN as the locus of augmented DA signaling to offset loss of TH during nigrostriatal neuron loss.
- 25 April 2025
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 254, 108918
Predictive factors for postoperative complications in nerve grafting neurorrhaphies: A multispecialty analysis using NSQIP data
- 25 April 2025
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 254, 108918
Predictive factors for postoperative complications in nerve grafting neurorrhaphies: A multispecialty analysis using NSQIP data